1. Ma J, Davis PB. What we know and what we do not know about cystic fibrosis transmembrane conductance regulator. Clin Chest Med 1998; 19: 459-471.

      2. Savov A, Angelicheva D, Balassopoulou A, Jordanova A, Noussia-Arvanitakis S, Kalaydjieva L. Double mutant alleles: are they rare? Hum Mol Genet 1995; 4: 1169-1179.

      3. Noone PG, Pue CA, Zhou Z, Friedman KJ, Wakeling El, Ganeshananthan M, Simon RH, Silverman LM, Knowles MR. Lung disease associated with the IVS8 5T allele of the CFTR gene. Am J Respir Crit Care Med 2000; 162: 1919-1924.

      4. Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, Jorissen M, Droogmans G, Reynaert I, Goossens M, Nilius B, Cassiman JJ. Polyvariant mutant CFTR genes: the polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 1998; 101: 487-496.

      5. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

      6. Férec C, Audrezet MP, Mercier B, Guillermit H, Moullier P, Quéré I, Verlingue C. Detection of over 98% cystic fibrosis mutations in a Celtic population. Nature Genet 1992; 1: 188-191.

      7. Entzian P, Müller E, Boysen A, Artlich A, Schwinger E, Schlaak M. Frequency of common cystic fibrosis gene mutations in chronic bronchitis patients. Scand J Clin Lab Invest 1995; 55: 263-266.

      8. Zielenski J, Rozmahel R, Bozon D, Kerem BS, Grzelczak Z, Riordan JR, Rommens J, Tsui LC. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 1991; 10: 214-228.

      9. Tanacković G, Barišić I, Gjergja-Matejčić R, Hećimović S, Pavelić J. The incidence of cystic fibrosis (CF) mutations among patients from Croatia. Clin Genet 2000; 58: 333-335.